Zoetis (NYSE:ZTS) Sets New 12-Month Low – Here’s What Happened

20 Mar 2026, 20:35 by Danessa Lincoln · The Markets Daily

Zoetis Inc. (NYSE:ZTS – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $114.44 and last traded at $114.6030, with a volume of 2084610 shares changing hands. The stock had previously closed at $115.99.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ZTS. Barclays assumed coverage on Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 price target on the stock. Bank of America increased their price objective on Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a report on Friday, February 13th. Piper Sandler reiterated a “neutral” rating and set a $135.00 price target (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. BTIG Research reissued a “buy” rating and issued a $160.00 price target on shares of Zoetis in a research note on Thursday, February 26th. Finally, Weiss Ratings raised Zoetis from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, March 12th. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $152.91.

Get Our Latest Stock Analysis on ZTS

Zoetis Stock Down 0.5%

The firm has a market cap of $48.73 billion, a price-to-earnings ratio of 19.17, a price-to-earnings-growth ratio of 1.79 and a beta of 0.95. The stock’s 50 day moving average is $124.58 and its 200 day moving average is $130.88. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS – Get Free Report) last released its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. During the same period in the prior year, the firm posted $1.40 earnings per share. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s payout ratio is presently 35.22%.

Hedge Funds Weigh In On Zoetis

Large investors have recently made changes to their positions in the business. Brighton Jones LLC lifted its stake in Zoetis by 180.4% during the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after purchasing an additional 2,978 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Zoetis by 6.2% during the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock worth $1,859,000 after acquiring an additional 657 shares in the last quarter. Intech Investment Management LLC boosted its stake in shares of Zoetis by 17.2% during the 1st quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock worth $1,374,000 after acquiring an additional 1,224 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of Zoetis by 73.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company’s stock valued at $522,000 after purchasing an additional 1,422 shares during the period. Finally, Stonebrook Private Inc. increased its stake in Zoetis by 8.3% in the 2nd quarter. Stonebrook Private Inc. now owns 1,513 shares of the company’s stock worth $236,000 after purchasing an additional 116 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Company Profile

(Get Free Report)

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.